Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

Drug repositioning now accounts for some 30% of new FDA-approved drugs, and success stories like Viagra (initially developed as a hypertension drug) have certainly proven the value of repositioning.

Read more:

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines (PDF, 706kb)